Showing 39,381 - 39,400 results of 109,696 for search '(( a point decrease ) OR ( 5 ((step decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.93s Refine Results
  1. 39381

    Genetic perturbation analysis of the stoichiometry control system. by Koji Ishikawa (703501)

    Published 2020
    “…The untagged dosage-compensated protein was expressed from multicopy plasmid pTOW40836 containing the native regulatory sequences, including promoter and 5´ and 3´ untranslated regions. If the target gene is subjected to dosage compensation, the level of the TAP-tagged target protein expressed only from the chromosome decreases upon an increase in gene copy number (Multi) compared to vector control (Single). …”
  2. 39382

    Discovery of Potent, Selective, and Brain-Penetrant 1<i>H</i>‑Pyrazol-5-yl‑1<i>H</i>‑pyrrolo[2,3‑<i>b</i>]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors by Makoto Fushimi (1714441)

    Published 2019
    “…Scaffold hopping and lead optimization of <i>N</i>-(2,4-difluorobenzyl)-3-(1<i>H</i>-pyrazol-5-yl)­imidazo­[1,2-<i>b</i>]­pyridazin-6-amine <b>1</b> guided by a cocrystal structure of compound <b>1</b> bound to ALK resulted in the identification of (6-(1-(5-fluoropyridin-2-yl)­ethoxy)-1-(5-methyl-1<i>H</i>-pyrazol-3-yl)-1<i>H</i>-pyrrolo­[2,3-<i>b</i>]­pyridin-3-yl)­((2<i>S</i>)-2-methylmorpholin-4-yl)­methanone <b>13</b> as a highly potent, selective, and brain-penetrable compound. …”
  3. 39383

    Table 1_Case report: A severe case of zoledronate-associated diffuse orbital inflammation and uveitis in a patient with metastatic breast cancer.docx by Pushpinder Kanda (5125214)

    Published 2024
    “…We report a case of simultaneous anterior uveitis and orbital inflammation associated with zoledronate infusion in a patient with metastatic breast cancer. …”
  4. 39384
  5. 39385
  6. 39386
  7. 39387
  8. 39388

    The effect of IL-17A on IκBζ - RGS4 signaling. by Hirotada Akiho (559455)

    Published 2014
    “…(<b>F</b>) The effect of IL-17A, IL-1β, or IL-4 on RGS 4 activity was assessed with or without SN50, a p65 translocation inhibitor, or IκBζ siRNA (n = 4∼5). …”
  9. 39389
  10. 39390

    Assessment of kidney function in the elderly: a population-based study by Marina Constante Dutra (12729314)

    Published 2022
    “…With regard to the glomerular filtration rate, 26.2% had a normal rate; 60.2% showed a slight decrease; 13.0% a moderate decrease; 0.5% severe kidney function decline; and 0.1% extreme fall. …”
  11. 39391

    Galactose-1-phosphate uridyltransferase (GalT), an <i>in vivo</i>-induced antigen of <i>Actinobacillus pleuropneumoniae</i> serovar 5b strain L20, provided immunoprotection against... by Fei Zhang (85787)

    Published 2018
    “…Indirect enzyme-linked immunosorbent assay (ELISA) confirmed that GALT specific antibodies could not be induced by inactivated APP L20 or MS71 whole cell bacterin preparations. A recombinant fusion GALT protein derived from APP L20, however has proven to be an effective cross-protective antigen against APP sevorar 1 MS71 (50%, 4/8) and APP sevorar 5b L20 (75%, 6/8). …”
  12. 39392
  13. 39393
  14. 39394

    RhoA signaling contributed to the JNK-regulated cell differentiation and migratory polarity formation. by Jiao Luo (156722)

    Published 2021
    “…(B) After 5 days with SP600125 treatment, ALPase staining showed that RhoA Q63L could partly rescue SP600125-regulated inhibition of mDPCs differentiation. …”
  15. 39395

    Stability of Afsup. by Gabriele Sass (335744)

    Published 2019
    “…B: 10AFsup was stored at 4°C for up to 12 months, and tested for protective activity against 5 μM pyoverdine (PYOV) every 3 months. A portion of the 10AFsup was stored at room temperature (RT), and tested after 12 months of storage. …”
  16. 39396

    Table 2_Temporary trigeminal ganglion stimulation can improve zoster-related trigeminal neuralgia: a retrospective study in a single center.docx by Kan Yue (1378518)

    Published 2025
    “…At the six-month follow-up, the mean VAS score decreased from preoperative 6.1 ± 1.5 to 2.5 ± 1.9, demonstrating a statistically significant reduction (t = 4.36, p < 0.05). …”
  17. 39397

    Table 1_Temporary trigeminal ganglion stimulation can improve zoster-related trigeminal neuralgia: a retrospective study in a single center.docx by Kan Yue (1378518)

    Published 2025
    “…At the six-month follow-up, the mean VAS score decreased from preoperative 6.1 ± 1.5 to 2.5 ± 1.9, demonstrating a statistically significant reduction (t = 4.36, p < 0.05). …”
  18. 39398

    Image 2_Temporary trigeminal ganglion stimulation can improve zoster-related trigeminal neuralgia: a retrospective study in a single center.tif by Kan Yue (1378518)

    Published 2025
    “…At the six-month follow-up, the mean VAS score decreased from preoperative 6.1 ± 1.5 to 2.5 ± 1.9, demonstrating a statistically significant reduction (t = 4.36, p < 0.05). …”
  19. 39399

    Image 1_Temporary trigeminal ganglion stimulation can improve zoster-related trigeminal neuralgia: a retrospective study in a single center.tif by Kan Yue (1378518)

    Published 2025
    “…At the six-month follow-up, the mean VAS score decreased from preoperative 6.1 ± 1.5 to 2.5 ± 1.9, demonstrating a statistically significant reduction (t = 4.36, p < 0.05). …”
  20. 39400